<Suppliers Price>

Hydroxyamine hydrochloride

Names

[ CAS No. ]:
5470-11-1

[ Name ]:
Hydroxyamine hydrochloride

[Synonym ]:
EINECS 226-798-2
MFCD00051089
Hydroxylammonium chloride
Ammonium, hydroxy-, chloride (1:1)
hydroxylamine,hydrochloride

Biological Activity

[Description]:

Hydroxyamine hydrochloride is a selective monoamine oxidase (MAO) inhibitor used for inhibiting of platelet aggregation. Hydroxyamine hydrochloride is an intermediate of organic synthesis[1].

[Related Catalog]:

Research Areas >> Cardiovascular Disease
Signaling Pathways >> Neuronal Signaling >> Monoamine Oxidase

[In Vitro]

Hydroxyamine hydrochloride (1 mM) inhibits the activity of MAO for 99.8%[1].

[References]

[1]. Roh JH, et al. Purification, characterization, and crystallization of monoamine oxidase from Escherichia coli K-12. Biosci Biotechnol Biochem. 1994 Sep;58(9):1652-6.

Chemical & Physical Properties

[ Density]:
1.67 g/mL at 25 °C(lit.)

[ Boiling Point ]:
56.5ºC at 760mmHg

[ Melting Point ]:
155-157 °C (dec.)(lit.)

[ Molecular Formula ]:
ClH4NO

[ Molecular Weight ]:
69.491

[ Exact Mass ]:
68.998138

[ PSA ]:
46.25000

[ LogP ]:
0.83660

[ Storage condition ]:
Store at RT.

[ Stability ]:
Substances to be avoided include strong oxidizing agents. Heating above 115 C may cause explosion; do not store above 65C. Moisture and air sensitive.

[ Water Solubility ]:
560 g/L (20 ºC)

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NC3675000
CHEMICAL NAME :
Hydroxylamine, hydrochloride
CAS REGISTRY NUMBER :
5470-11-1
LAST UPDATED :
199710
DATA ITEMS CITED :
46
MOLECULAR FORMULA :
Cl-H.H3-N-O
MOLECULAR WEIGHT :
69.50
WISWESSER LINE NOTATION :
ZQ &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
141 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
408 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
125 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
70 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
49500 mg/kg/25W-I
TOXIC EFFECTS :
Endocrine - changes in spleen weight Endocrine - changes in thyroid weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2478 mg/kg/6D-C
TOXIC EFFECTS :
Behavioral - food intake (animal) Blood - changes in leukocyte (WBC) count Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TYPE OF TEST :
Sister chromatid exchange
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
25 mg/L
REFERENCE :
IJEBA6 Indian Journal of Experimental Biology. (Publications & Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- Volume(issue)/page/year: 20,726,1982 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 38950 No. of Facilities: 1202 (estimated) No. of Industries: 18 No. of Occupations: 11 No. of Employees: 6578 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 38950 No. of Facilities: 1258 (estimated) No. of Industries: 20 No. of Occupations: 26 No. of Employees: 15258 (estimated) No. of Female Employees: 4469 (estimated)

Safety Information

[ Symbol ]:

GHS05, GHS07, GHS08, GHS09

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H290-H302 + H312-H315-H317-H319-H351-H373-H410

[ Precautionary Statements ]:
P273-P280-P305 + P351 + P338-P501

[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ Hazard Codes ]:
Xn:Harmful

[ Risk Phrases ]:
R22;R36/38;R43;R48/22;R50

[ Safety Phrases ]:
S22-S24-S37-S61

[ RIDADR ]:
UN 2923 8/PG 2

[ WGK Germany ]:
3

[ RTECS ]:
NC3675000

[ Packaging Group ]:
III

[ Hazard Class ]:
8

[ HS Code ]:
2935009090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2935009090

[ Summary ]:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

Articles

The identification of a novel SIRT6 modulator from Trigonella foenum-graecum using ligand fishing with protein coated magnetic beads.

J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 968 , 105-11, (2014)

SIRT6 is a histone deacetylase that has been proposed as a potential therapeutic target for metabolic disorders and the prevention of age-associated diseases. Thus the identification of compounds that...

Superparamagnetic iron oxide nanoparticles exacerbate the risks of reactive oxygen species-mediated external stresses.

Arch. Toxicol. 89(3) , 357-69, (2015)

Superparamagnetic iron oxide nanoparticles (IONPs) have been widely applied in numerous biomedical fields. The evaluation of the toxicity of IONPs to the environment and human beings is indispensable ...

Novel oral phosphate binder with nanocrystalline maghemite-phosphate binding capacity and pH effect.

Int. J. Pharm. 482(1-2) , 21-6, (2015)

Hyperphosphatemia is one of the main risk factors contributing to morbidity and mortality in patients with end stage renal disease. The demand for a new phosphate binder is continuously increasing sin...


More Articles


Related Compounds